Item

Clinical impact of variations in laboratory measurements of growth hormone and insulin-like growth factor I on the classification of acromegaly disease activity status in the United Kingdom

Loughrey, P. B.
; 
Ayuk, J.
; 
Bashir, B.
; 
Higham, C. E.
; 
Ho, J. H.
; 
Monaghan, P. J.
; 
Wark, G.
; 
Adam, S.
Citations
Google Scholar:
Lookup
Altmetric:
Abstract
Authors
Loughrey, P. B.
Ayuk, J.
Bashir, B.
Higham, C. E.
Ho, J. H.
Monaghan, P. J.
Wark, G.
Adam, S.
Affiliation
Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast BT9 7AE, United Kingdom. Regional Centre for Endocrinology and Diabetes, Belfast Health and Social Care Trust, Belfast, United Kingdom. University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom. Department of Endocrinology, The Christie NHS Foundation Trust, Manchester, United Kingdom. Division of Cancer Sciences, The University of Manchester, Manchester M13 9PL, United Kingdom. The Christie Pathology Partnership, The Christie NHS Foundation Trust, Manchester, United Kingdom. Supraregional Assay Service Peptide Hormones Centre and UK NEQAS Guildford Peptide Hormones Scheme, Clinical Laboratory, Royal Surrey NHS Foundation Trust Guildford, Surrey, United Kingdom.
Description
Date
2025
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Article
Citation
Loughrey PB, Ayuk J, Bashir B, Higham CE, Ho JH, Monaghan PJ, et al. Clinical impact of variations in laboratory measurements of growth hormone and insulin-like growth factor I on the classification of acromegaly disease activity status in the United Kingdom. European Journal of Endocrinol. 2025 Mar 3;192(3):L7-L11. PubMed PMID: 40037929. Epub 2025/03/05. eng.
Journal Title
Journal ISSN
Volume Title
URI
https://christie.openrepository.com/handle/10541/627585
Embedded videos